Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-02 · accession 0001628280-24-000169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-03 | 2024-01-02 | VIR | Pang Phillip | EVP, Chief Medical Off | M - OptEx | $1.38 | +80.0K | 268.0K | +43% | +$110.5K |
| DM | 2024-01-03 | 2024-01-02 | VIR | Pang Phillip | EVP, Chief Medical Off | M - OptEx | $1.38 | -80.0K | 0 | -100% | -$110.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | M | A | 18,833 | $0.86 | 206,833 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-02 | M | A | 13,576 | $1.58 | 220,409 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-02 | M | A | 47,591 | $1.53 | 268,000 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | M | D | 18,833 | $0.86 | 0 | D | $0.86 · — to 2027-03-09 | 18,833 Common Stock | (F1) 1/4 of the shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | M | D | 47,591 | $1.53 | 0 | D | $1.53 · — to 2028-04-27 | 47,591 Common Stock | (F3) 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | M | D | 13,576 | $1.58 | 0 | D | $1.58 · — to 2028-07-19 | 13,576 Common Stock | (F2) 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter. |